Profit Confidential pulled together a number of recent reports showing that the CBD oil stock market is set to break out in the next few years, carving out its own niche among marijuana stocks. Forbes, forecasted an increase of 700 percent by 2020, while Hemp Business Journal sees CBD oil reaching $2.1 billion by that same year. It is a mature market, far removed from the weed smoking, pot smoking stoner days of yore.
Even as cannabis stocks continue to experience volatility, CBD oil sees record profits. The sector is primed for an influx of investors. With that in mind, here are three CBD oil stocks that will make you rethink your portfolio:
Isodiol International Inc.
Global Bioactive CBD oil company Isodiol International Inc. (CSE:ISOL) (ISOLF) announced recently the acquisition of several global assets, placing them on a level playing field with any of the top marijuana stocks in the industry. Along with their recent deals, the company has begun to develop a new facility in China where they plan to take certified organic hemp and extract cannabinoids and terpenes.
Isodiol’s new strategic assets in the U.K., Brazil, and China look like they will give the company true global dominance in the growing CBD oil sector; a pot stock so steeped in extracts that CBD oil stock seems the more appropriate term. “These transactions mark major milestones for Isodiol. The acquisitions ensure the company has a continued source of CBD and scalability of production as our international expansion continues to generate additional market demand for our products,” remarked CEO Marcos Agramont.
Isodiol currently trades at $0.84 on the OTC markets, with a market cap of $240 million. With the growth in the CBD oil market set on an upwards trajectory, now may be the time for investors to